Literature DB >> 12716787

Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety.

Wasim A Haque1, Elif Arioglu Oral, Kelly Dietz, Anne M Bowcock, Anil K Agarwal, Abhimanyu Garg.   

Abstract

OBJECTIVES: Familial partial lipodystrophy, Dunnigan variety (FPLD), is an autosomal dominant disorder due to missense mutations in the lamin A/C (LMNA) gene encoding nuclear lamina proteins. It is characterized by loss of subcutaneous fat from the extremities and trunk and accumulation of fat in the head and neck region beginning at puberty. Patients with FPLD are predisposed to metabolic complications of insulin resistance such as diabetes. We sought to identify risk factors for diabetes in patients with FPLD. RESEARCH DESIGN AND METHODS: A cross-sectional study comparing clinical, biochemical, and anthropometric variables and LMNA genotypes in FPLD patients with and without diabetes.
RESULTS: We studied 52 women and 24 men with FPLD from 18 different families. Twenty-eight women (54%) but only four men (17%) had diabetes (P < 0.001); therefore further comparisons were mostly limited to women. Compared with women without diabetes, those with diabetes had higher BMI (median values 23 vs. 24 kg/m(2), respectively; P = 0.03), increased chin skinfold thickness (10 vs. 20 mm; P = 0.001), lower rates of nulliparity (60% vs. 28%; P = 0.04), and higher levels of fasting serum triglycerides (2.4 vs. 3.5 mmol/l; P < 0.001) but similar serum leptin levels (3.4 vs. 3.6 ng/ml; P = 0.9). The prevalence of diabetes was not related to age, menopausal status, family history of type 2 diabetes in unaffected relatives, or LMNA genotype.
CONCLUSIONS: We conclude that increased adiposity as reflected by excess subcutaneous fat accumulation in the chin region and parity may predispose women with FPLD to develop diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716787     DOI: 10.2337/diacare.26.5.1350

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  A Novel LMNA Mutation Causes Altered Nuclear Morphology and Symptoms of Familial Partial Lipodystrophy (Dunnigan Variety) with Progeroid Features.

Authors:  B Saha; D Lessel; F M Hisama; D F Leistritz; K Friedrich; G M Martin; C Kubisch; J Oshima
Journal:  Mol Syndromol       Date:  2010-09-14

Review 2.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

3.  Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy.

Authors:  Jean Y Park; Edward D Javor; Elaine K Cochran; Alex M DePaoli; Phillip Gorden
Journal:  Metabolism       Date:  2007-04       Impact factor: 8.694

Review 4.  Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome.

Authors:  C Ronald Kahn; Guoxiao Wang; Kevin Y Lee
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

Review 5.  Adipose tissue angiogenesis: impact on obesity and type-2 diabetes.

Authors:  Silvia Corvera; Olga Gealekman
Journal:  Biochim Biophys Acta       Date:  2013-06-12

6.  The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.

Authors:  Kari M Wojtanik; Keith Edgemon; Srikant Viswanadha; Brigette Lindsey; Martin Haluzik; Weiping Chen; George Poy; Marc Reitman; Constantine Londos
Journal:  J Lipid Res       Date:  2009-02-05       Impact factor: 5.922

7.  A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease.

Authors:  Hitomi Imachi; Koji Murao; Shouji Ohtsuka; Mako Fujiwara; Tomie Muraoka; Hitoshi Hosokawa; Toshihiko Ishida
Journal:  Endocrine       Date:  2008-11-15       Impact factor: 3.633

8.  Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations.

Authors:  L Subramanyam; V Simha; A Garg
Journal:  Clin Genet       Date:  2009-12-22       Impact factor: 4.438

Review 9.  Lipodystrophies: disorders of adipose tissue biology.

Authors:  Abhimanyu Garg; Anil K Agarwal
Journal:  Biochim Biophys Acta       Date:  2009-01-07

10.  Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy-causing mutations.

Authors:  Dan N Simon; Tera Domaradzki; Wilma A Hofmann; Katherine L Wilson
Journal:  Mol Biol Cell       Date:  2012-12-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.